---
title: "GUANGJI PHARMA: 2'-Fucosyllactose Approved"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/247967875.md"
description: "GUANGJI PHARMA announced that the administrative license application for 2'-fucosyllactose submitted by the company has passed the review by the National Health Commission and has been announced. 2'-FL is a oligosaccharide that is abundant in breast milk and has various functions. GUANGJI PHARMA's 2'-FL has officially passed approval and obtained a new variety license for food additives, marking an important progress in the field of synthetic biology applications for the company. However, the future production, market acceptance, sales situation, and performance may still be affected by uncertainties such as changes in market demand and adjustments in policies and regulations"
datetime: "2025-07-10T09:58:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/247967875.md)
  - [en](https://longbridge.com/en/news/247967875.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/247967875.md)
---

# GUANGJI PHARMA: 2'-Fucosyllactose Approved

GUANGJI PHARMA announced that the administrative license application for 2'-fucosyllactose submitted by the company has passed the review by the National Health Commission and has been announced. 2'-FL is a oligosaccharide that is abundant in breast milk and has various functions. The approval of 2'-FL by GUANGJI PHARMA and the acquisition of a new variety license for food additives represent an important advancement in the company's synthetic biology application field. However, the future production, market acceptance, sales situation, and performance may still be affected by uncertainties such as changes in market demand and adjustments in policies and regulations

### Related Stocks

- [000952.CN](https://longbridge.com/en/quote/000952.CN.md)

## Related News & Research

- [Flow Pharma U.S. Patent Application Allowed for Issuance Covering Broad-Spectrum Ebola Therapy](https://longbridge.com/en/news/287076761.md)
- [15:37 ETMuse Communications Celebrates 10 Years of Award-Winning Legal Marketing and Public Relations](https://longbridge.com/en/news/286811115.md)
- [Nuclear reactor developer Deep Fission eyes $1.66 billion valuation in US IPO](https://longbridge.com/en/news/287062992.md)
- [PRECIOUS-Treasury yields, dollar weigh on gold amid inflation concerns](https://longbridge.com/en/news/286929968.md)
- [PRECIOUS-Gold edges higher from over 1-1/2-month low but higher yields cap gains](https://longbridge.com/en/news/286745980.md)